Drug Profile
Research programme: wound healing therapeutics - Pacific Northwest Biotechnology
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Pacific Northwest Biotechnology
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Wounds
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Wounds in USA (IM)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Wounds in USA (Intraperitoneal)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Wounds in USA (SC)